diclofenac – pharmaceutical daily

April 3, 2019 Off

CSC Pharmaceuticals Announces the Launch of the Innovative Migraine and Pain Treatment Developed by APR Applied Pharma Research

BALERNA, Switzerland–(BUSINESS WIRE)–APR Applied Pharma Research’s patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other…

October 21, 2016 Off

Anti-inflammatory pills tied to heart failure risk

By Dino Mustafić

(Reuters Health) – Widely used non-steroidal anti-inflammatory drugs (NSAIDs) are associated with an increased risk of heart failure – even in people without a history of cardiac issues, a recent study suggests.

November 24, 2015 Off

Futura Medical’s two painkillers cleared path for Europe

By Dino Mustafić

Futura Medical, a transdermal technology specialist, has received by an European regulator clarity on the regulatory pathways for its two topical pain relief products, TPR100 (diclofenac) and TIB200 (ibuprofen).